Placental biologics firmMiMedxand exosome companyKimera Labsboth recently received FDA warning letters. The letter to MiMedxwas related to its placental biologics products and procedures. The new warning to Kimera Labs was about its exosome products and an amniotic product. Let’s co...
Recent studies have also explored the use of exosome-mimicking nanoparticles, which leverage the natural ability of exosomes to cross the BBB. These nanoparticles, loaded with therapeutic antibodies against alpha-synuclein, have shown potential in treating Parkinson’s disease through reducing the accumula...